Turning stats into outcomes
February 23, 2012
If Australia had paid English prices for generic simvastatin during May 2010-October 2011, its PBS spending could have been reduced from $150 million to just A$20 million, says a leading health economist.
April 19, 2011
Clinical trials in Australia are neglecting cancer types responsible for the heaviest burden of disease in the category, suggests an analysis of data from the Australian New Zealand Clinical Trials Registry and the US-based registry ClinicalTrials.gov.
PharmaTimes 2013 Copyright | RSS Feed Subscriptions